|
|
|
|
|
Friday, 30 June 2006 09:07 | BNN: British Nursing News Online · www.bnn-online.co.uk
|
|
500 people are needed for a trial to determine whether chemicals in cannabis can slow the impact of multiple sclerosis (MS).
The study is taking place in collaboration with Professor Alan Thompson at the National Hospital for Neurology and Neurosurgery (part of University College London Hospitals NHS Foundation Trust) and Institute of Neurology, University College London.
Prof John Zajicek, of the Peninsula Medical School and Derriford Hospital in Plymouth, will lead the research.
Prof Zajicek said; "This trial will build on our previous study which, coupled with our work in the laboratory, suggested that THC one component of cannabis could have a protective effect on nerves”.
"Multiple Sclerosis is a very unpredictable disease. Currently there are few medicines which are effective in treating MS and none have been shown to have any effect in the progressive stages of the disease."
"If this study demonstrates that cannaboids do have a longer term effect on the progression of disability, there are potentially far-reaching implications, not only for the health of people with MS, but also for those with other neurodegenerative conditions”.
|
|
-
0 comments on this story
|
|
Home Top Disclaimer Site
Credits
Nursing Jobs | Just for Nurses | Nursing Agencies List | Charles Bloe Training
Nursing Portal | Nursing Events | Brutish Nursing | British Nursing Websites
Website Development and SEO Services
|
|
|